These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14504083)

  • 1. Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages.
    Konno A; Wada T; Schurman SH; Garabedian EK; Kirby M; Anderson SM; Candotti F
    Blood; 2004 Jan; 103(2):676-8. PubMed ID: 14504083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome.
    Lutskiy MI; Beardsley DS; Rosen FS; Remold-O'Donnell E
    Blood; 2005 Oct; 106(8):2815-7. PubMed ID: 15985539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.
    Trifari S; Scaramuzza S; Catucci M; Ponzoni M; Mollica L; Chiesa R; Cattaneo F; Lafouresse F; Calvez R; Vermi W; Medicina D; Castiello MC; Marangoni F; Bosticardo M; Doglioni C; Caniglia M; Aiuti A; Villa A; Roncarolo MG; Dupré L
    J Allergy Clin Immunol; 2010 Feb; 125(2):439-448.e8. PubMed ID: 20159256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.
    Wada T; Konno A; Schurman SH; Garabedian EK; Anderson SM; Kirby M; Nelson DL; Candotti F
    J Clin Invest; 2003 May; 111(9):1389-97. PubMed ID: 12727931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants.
    Davis BR; Yan Q; Bui JH; Felix K; Moratto D; Muul LM; Prokopishyn NL; Blaese RM; Candotti F
    Clin Immunol; 2010 Apr; 135(1):72-83. PubMed ID: 20123155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo reversion of an inherited mutation in a Chinese patient with Wiskott-Aldrich syndrome.
    Xie JW; Zhang ZY; Wu JF; Liu DW; Liu W; Zhao Y; Jiang LP; Tang XM; Wang M; Zhao XD
    Hum Immunol; 2015 Jun; 76(6):406-13. PubMed ID: 25862925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family.
    Wada T; Schurman SH; Jagadeesh GJ; Garabedian EK; Nelson DL; Candotti F
    Blood; 2004 Sep; 104(5):1270-2. PubMed ID: 15142877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wiskott-Aldrich syndrome: another piece in the puzzle.
    Notarangelo LD; Mori L
    Clin Exp Immunol; 2005 Feb; 139(2):173-5. PubMed ID: 15654814
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
    Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
    J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.
    Wada T; Schurman SH; Otsu M; Garabedian EK; Ochs HD; Nelson DL; Candotti F
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8697-702. PubMed ID: 11447283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes.
    Wen KK; Han SS; Vyas YM
    J Allergy Clin Immunol; 2020 Jan; 145(1):324-334. PubMed ID: 31604087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation.
    Park JY; Kob M; Prodeus AP; Rosen FS; Shcherbina A; Remold-O'Donnell E
    Clin Exp Immunol; 2004 Apr; 136(1):104-10. PubMed ID: 15030520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome.
    Davis BR; Dicola MJ; Prokopishyn NL; Rosenberg JB; Moratto D; Muul LM; Candotti F; Michael Blaese R
    Blood; 2008 May; 111(10):5064-7. PubMed ID: 18332229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the molecular basis of Wiskott-Aldrich syndrome.
    Abo A
    Cell Mol Life Sci; 1998 Oct; 54(10):1145-53. PubMed ID: 9817992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wiskott-Aldrich syndrome in a female.
    Lutskiy MI; Sasahara Y; Kenney DM; Rosen FS; Remold-O'Donnell E
    Blood; 2002 Oct; 100(8):2763-8. PubMed ID: 12351383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome.
    Boztug K; Germeshausen M; Avedillo Díez I; Gulacsy V; Diestelhorst J; Ballmaier M; Welte K; Maródi L; Chernyshova L; Klein C
    Clin Genet; 2008 Jul; 74(1):68-74. PubMed ID: 18479478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes.
    Han SS; Wen KK; Vyas YM
    Oncogene; 2021 Jan; 40(2):345-354. PubMed ID: 33139832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
    Du HQ; Zhang X; An YF; Ding Y; Zhao XD
    Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient.
    Boztug K; Baumann U; Ballmaier M; Webster D; Sandrock I; Jacobs R; Lion T; Preuner S; Germeshausen M; Hansen G; Welte K; Klein C
    Haematologica; 2007 Mar; 92(3):e43-5. PubMed ID: 17405757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.